UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001284
Receipt number R000001565
Scientific Title Large doses of methylcobalamin for juvenile muscular atrophy of distal upper extremity
Date of disclosure of the study information 2008/08/02
Last modified on 2015/11/21 11:50:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Large doses of methylcobalamin for juvenile muscular atrophy of distal upper extremity

Acronym

Methylcobalamin for juvenile muscular atrophy of distal upper extremity

Scientific Title

Large doses of methylcobalamin for juvenile muscular atrophy of distal upper extremity

Scientific Title:Acronym

Methylcobalamin for juvenile muscular atrophy of distal upper extremity

Region

Japan


Condition

Condition

juvenile muscular atrophy of distal upper extremity

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether large doses of methylcobalamin improve amyotrophy in patients with juvenile muscular atrophy of distal upper extremity (Hirayama disease).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Overall Neuropathy Limitations Scale

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

methylcobalamin 25mg/day (Day 1-10)
methylcobalamin 25mg/day, every 4 weeks, 5 cycles

Interventions/Control_2

methylcobalamin 1500 microg/day, 6 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

35 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients with amyotrophy
2) Written informed consent
3) Outpatient

Key exclusion criteria

1) Patients with critical illness
2) Pregnant or lactating woman
3) Within 3 months from other clinical trial
4) Patients who are not appropriate to participate to the trial.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Kuwabara

Organization

Chiba University Graduate School of Medicine

Division name

Department of Neurology

Zip code


Address

Inohana 1-8-1, Chuo-ku, Chiba

TEL

043-222-7171

Email



Public contact

Name of contact person

1st name
Middle name
Last name Sonoko Misawa

Organization

Chiba University Graduate School of Medicine

Division name

Department of Neurology

Zip code


Address

Inohana 1-8-1, Chuo-ku, Chiba

TEL

043-222-7171

Homepage URL


Email

sonoko.m@mb.infoweb.ne.jp


Sponsor or person

Institute

Chiba University Graduate School of Medicine, Department of Neurology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 08 Month 02 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 10 Month 25 Day

Date of IRB


Anticipated trial start date

2008 Year 06 Month 01 Day

Last follow-up date

2013 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2008 Year 08 Month 01 Day

Last modified on

2015 Year 11 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001565


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name